Pregled bibliografske jedinice broj: 67330
New quinolones in the treatment of urogenital infections. 2nd Croatian Congress on Infectious Diseases with International Participation - Abstract book
New quinolones in the treatment of urogenital infections. 2nd Croatian Congress on Infectious Diseases with International Participation - Abstract book // New quinolones in the treatment of urogenital infections / Jeren, Tatjana (ur.).
Zagreb: Croatian Society for Infectious Diseases, 2000. (predavanje, nije recenziran, sažetak, stručni)
CROSBI ID: 67330 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
New quinolones in the treatment of urogenital infections. 2nd Croatian Congress on Infectious Diseases with International Participation - Abstract book
Autori
Schönwald, Slavko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
New quinolones in the treatment of urogenital infections
/ Jeren, Tatjana - Zagreb : Croatian Society for Infectious Diseases, 2000
Skup
2nd Croatian Congress on Infectious Diseases with International Participation
Mjesto i datum
Dubrovnik, Hrvatska, 24.09.2000. - 27.09.2000
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Nije recenziran
Ključne riječi
quinolones; therapy
Sažetak
A whole range of new quinolones have been introduced into clinical practice in the last several aears. Apart from ciprofloxacin, among the well known are trovafloxacin, gatifloxacin, gemifloxacin, clinafloxacin, moxyfloxacin. Basic characteristics of these quinolones is their activity against gram-negative bacteria, gram-positive bacteria and activity against Chlamydia an mycoplasma which cause genital infections. Taking into consideration their good pharmacokinetic features -penetration into genital tissues - we can assume that these quinolones will be even more effective in the treatment of some sexually transmitted diseases (nonspecific urethritis cervicitis) as well as in the treatment of urinary tract infections. For now, only a small number of clinical studies confirm this thesis but there is a good assumption that soon there will be more such studies and that quinolones will be administered in the above mentioned indications.
Izvorni jezik
Engleski